Article info

Download PDFPDF

Extended report
Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis
  1. Correspondence to Professor Deborah Symmons, arc Epidemiology Unit, The University of Manchester, Stopford Building, Oxford Road, Manchester M13 9PT, UK; Deborah.Symmons{at}manchester.ac.uk
View Full Text

Citation

Farragher TM, Lunt M, Fu B, et al
Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis

Publication history

  • Accepted October 3, 2009
  • First published October 26, 2009.
Online issue publication 
March 17, 2010

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.